These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 10470598)
1. Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile. Tosti ME; Traversa G; Bianco E; Mele A Ital J Gastroenterol Hepatol; 1999; 31(5):388-91. PubMed ID: 10470598 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccination: risk-benefit profile and the role of systematic reviews in the assessment of causality of adverse events following immunisation. Jefferson T; Traversa G J Med Virol; 2002 Jul; 67(3):451-3. PubMed ID: 12116044 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Mikaeloff Y; Caridade G; Assi S; Tardieu M; Suissa S; Brain; 2007 Apr; 130(Pt 4):1105-10. PubMed ID: 17276994 [TBL] [Abstract][Full Text] [Related]
4. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E; Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332 [TBL] [Abstract][Full Text] [Related]
5. Vaccinations and risk of central nervous system demyelinating diseases in adults. DeStefano F; Verstraeten T; Jackson LA; Okoro CA; Benson P; Black SB; Shinefield HR; Mullooly JP; Likosky W; Chen RT; Arch Neurol; 2003 Apr; 60(4):504-9. PubMed ID: 12707063 [TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation. Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389 [TBL] [Abstract][Full Text] [Related]
7. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign. Mele A; Mariano A; Tosti ME; Stroffolini T; Pizzuti R; Gallo G; Ragni P; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E; Clin Infect Dis; 2007 Feb; 44(3):e17-24. PubMed ID: 17205431 [TBL] [Abstract][Full Text] [Related]
8. Development of multiple sclerosis after vaccination against hepatitis B: a study based on human leucocyte antigen haplotypes. Ozakbas S; Idiman E; Yulug B; Pakoz B; Bahar H; Gulay Z Tissue Antigens; 2006 Sep; 68(3):235-8. PubMed ID: 16948644 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination. Mele A; Stroffolini T; Zanetti AR J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041 [TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B vaccination. Advocating for a protection principle]. Aron E Bull Acad Natl Med; 2002; 186(2):361-6; discussion 366-8. PubMed ID: 12145843 [TBL] [Abstract][Full Text] [Related]
11. [Long-term efficacy of infant hepatitis B immunization program]. Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514 [TBL] [Abstract][Full Text] [Related]
12. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content. Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B vaccine and risk of multiple sclerosis. DeStefano F; Verstraeten T; Chen RT Expert Rev Vaccines; 2002 Dec; 1(4):461-6. PubMed ID: 12901584 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B vaccination and the risk of multiple sclerosis. Ascherio A; Zhang SM; Hernán MA; Olek MJ; Coplan PM; Brodovicz K; Walker AM N Engl J Med; 2001 Feb; 344(5):327-32. PubMed ID: 11172163 [TBL] [Abstract][Full Text] [Related]
15. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Mikaeloff Y; Caridade G; Suissa S; Tardieu M Neurology; 2009 Mar; 72(10):873-80. PubMed ID: 18843097 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Mikaeloff Y; Caridade G; Rossier M; Suissa S; Tardieu M Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1176-82. PubMed ID: 18056563 [TBL] [Abstract][Full Text] [Related]
18. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults. Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437 [TBL] [Abstract][Full Text] [Related]
19. [Cost-effectiveness analysis of different alternatives of universal vaccination against hepatitis B in the region of Murcia]. Guillén Grima F; Espín Ríos MI Med Clin (Barc); 1995 Feb; 104(4):130-6. PubMed ID: 7898156 [TBL] [Abstract][Full Text] [Related]
20. Benefits of early hepatitis B immunization programs for newborns and infants. Van Herck K; Van Damme P Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]